Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days
Richard K. Burt, Xiaoqiang Han, Kathleen Quigley, Indira Arnautovic, Sanjiv J. Shah, Daniel Lee, Benjamin H. Freed, Borko Jovanovic, Irene Helenowski
Topics & Concepts
MedicineRituximabFludarabineInternal medicineRegimenNeutropeniaCyclophosphamideTransplantationGastroenterologyFebrile neutropeniaSurgeryChemotherapyLymphomaSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and Dermatomyositis